TOPLINE: Four clinical organizations jointly released a clinical advisory with evidence-based nutrition and lifestyle interventions to enhance glucagon-like peptide 1 (GLP-1) treatment outcomes for obesity. METHODOLOGY: An expert group comprised of multiple clinical and research disciplines assessed the literature to identify pragmatic priorities for nutrition and other lifestyle interventions relevant to GLP-1 treatment for obesity. … Read more
TOPLINE: In a study, patients who received a team-based intervention involving education and mobile health support in the emergency department (ED) had greater reduction in systolic blood pressure (SBP) at 6 months than those who received standard discharge care. METHODOLOGY: A randomized clinical trial enrolled 574 adult patients (mean age, 51.1 years) with elevated BP … Read more
Patients with early Alzheimer’s disease (AD) who initiated lecanemab treatment at a specialty memory clinic showed an expected and manageable side-effect profile, new research showed. “The findings are very reassuring,” Barbara Joy Snider, MD, PhD, professor of neurology, and director of the Memory Diagnostic Center and Knight ADRC Clinical Trials Unit, Washington University School of … Read more
For the first time, the number of Americans living with Alzheimer’s disease (AD) has surpassed 7 million, according to the Alzheimer’s Disease Facts and Figures report released this week. An estimated 7.2 million people aged 65 years or older are now living with AD, up from an estimated 6.9 million in the 2024 report. Three … Read more
The widely used FAST acronym remains the best tool for helping bystanders recognize stroke symptoms, despite efforts to expand it to BE-FAST. A new study showed that adding Balance and Eye changes (BE) to FAST — Face drooping, Arm weakness, Speech difficulty, and Time to call 911 — does not significantly increase the likelihood of … Read more